TAILIEUCHUNG - THE COLLEGE ADVANTAGE: WEATHERING THE ECONOMIC STORM 2013

California also has a “General Child Care” program, in which the state contracts directly with licensed centers or networks of FCC homes to provide ECE. This program was established in the 1960s through Title 5, and sets standards for higher staff qualifications than is required under regular licensing. Payment is set at a standard statewide reimbursement rate. Funding for this program was $797 million with an enrollment of 86,169 in 2010–2011 (Ehlers 2011). There are 1,358 General Child Care centers/providers in the state (CCCRRN 2009). The California State Preschool Program, which provides full- and part-day programs, served 116,847 children at a cost of $439. | QEORgETOW UNlVERSITY Georgetown Public Policy Institute ANTHONY P. CARNEVALE TAMARA JAYASUNDERA BAN CHEAH Center on Education and the Workforce THE COLLEGE ADVANTAGE _ WEATHERING THE ECONOMIC STORM ACKNOWLEDGEMENTS We would like to express our gratitude to the individuals and organizations that have made this report possible. First we thank Lumina Foundation and the Bill and Melinda Gates Foundation for their support of our research over the past few years and in particular we are grateful for the support of Jamie Merisotis Holly Zanville Dewayne Matthews Daniel Greenstein Daniel Pitasky Elizabeth Gonzalez and Elise Miller. We are honored to be partners in their mission of promoting postsecondary access and completion for all Americans. We undertook this report to help advance the discussion and understanding of the effect of education on employment in the Great Recession and recovery. We believe the role education has had in job losses and job gains in the recession and recovery has not received its due emphasis because media attention has focused on how men and women have been affected differently during the stormy economic period. Many have contributed their thoughts and feedback to the research methodological decisions content and design of this report. That said all errors omissions and views remain the responsibility of the authors. Specifically we wish to thank Nancy Lewis the report s editor who made us look like better writers than we are Janna Matherly and Woodpile Studios our designers who made the report easy on the eye Martha Hamilton for editorial assistance in an early draft of the report Cindy Decker for her comments and suggestions for reorganizing the paper Our associates Artem Gulish and Shuangyuan Wei for their excellent research assistance Our colleagues Jeff Strohl Steve Ross and Nicole Smith for their insight feedback and strong data and research expertise and Andrea Porter and Andrew Hanson for editorial assistance in the preparation and .

• Kinh tế học
• Metastatic Pancreatic Cancer
• Pancreatic Cancer
• Clinical Course
• Nutrition in Healthy Children
• Growth and Development
• Pediatric Cardiology
• BMC Cancer
• Enzyme gamma glutamyltransferase
• Serum gamma glutamyltransferase
• Overall survival
• Recurrent pancreatic ductal adenocarcinoma
• Recurrent pancreatic cancer
• Gemcitabine nab paclitaxel
• Combination chemotherapy
• Liver metastases
• Liver directed therapy
• Systemic chemotherapy
• Metastatic pancreatic ductal adenocarcinoma
• Nab paclitaxel
• Pancreatic adenocarcinoma
• Randomized phase III trial
• Progressive disease
• Subgroup analysis
• MPACT trial
• Subsequent therapy
• Weekly nab paclitaxel plus gemcitabine
• Phase II study
• H 1 parvovirus
• Oncolytic virotherapy
• Pancreatic ductal adenocarcinoma
• Clinical protocol
• Body mass index
• Prognostic factors
• Physical activity
• Skeletal muscle density
• Metastatic pancreatic adenocarcinoma
• Prognostic factor
• Journal of Biology
• CRISPR/dCas9 activation
• Pancreas cancer
• Pancreatic ductal adenocarcinoma (PDAC)
• Metastatic pancreatic cancer cells
• Real life
• First line chemotherapy
• Locally advanced
• Metastatic disease
• Locally advanced pancreatic adenocarcinoma
• Kaplan–Meier method
• Second line chemotherapy
• Venous thromboembolism
• Predictive value
• Khorana score
• Gemcitabine chemotherapy
• Therapeutics strategy
• Laboratory parameters
• Clinicopathological factors
• White blood cell
• Survival
• Endoscopic Management
• Palliative Therapy